Table 2.

Morphine consumption, NRS and additionnal analgesics during the first 48 h in the two studied groups

	CWI group (n = 26)	SABP group (n = 20)	p Value
Dose of morphine (mg)
Total to 48 h	21 [11–36]	11 [5–19]	< 0.01
Titration (h0)	5 [4–8]	2 [0–3.5]	< 0.01
h0-h6	10 [7–15]	7 [4–10]	0.01
h0-h24	18 [10–31]	10 [6–13]	< 0.01
NRS
h0	5 [4–6]	0 [0–4]	< 0.01
h6	2 [0–4]	0 [0–3]	0.13
h24	0.5 [0–3]	0 [0–2]	0.41
h48	0 [0–2]	0 [0–2]	0.85
Additional analgesics
Nefopam	6 (23)	1 (5)	0.20
Tramadol	5 (19)	0 (0)	0.06
Ketoprofen	4 (15)	5 (25)	0.66
Nausea and vomiting	8 (30)	5 (25)	0.7
NIV	6 (23)	3 (15)	0.7
Length of stay
ICU (h)	41 [25–69]	24 [20–42]	0.03
Hospital (days)	8 [7–9]	6 [5–8]	0.03

Data are presented as median [IQR] or n (%)

CWI catheter wound infiltration group, SAPB serratus anterior plane block group, NRS visual analogic scale, NIV noninvasive ventilation, ICU intensive care unit